二氧化碳激光切除术作为治疗大面积睑黄褐斑的新疗法:长期疗效和安全性

IF 3.7 2区 医学 Q1 OPHTHALMOLOGY British Journal of Ophthalmology Pub Date : 2024-09-05 DOI:10.1136/bjo-2024-325581
Dingqiao Wang, Zhen Mao, Zuohong Li, Wuyou Gao, Yixin Qu, Xingyi Li, Yuzhen Jiang, Xianchai Lin
{"title":"二氧化碳激光切除术作为治疗大面积睑黄褐斑的新疗法:长期疗效和安全性","authors":"Dingqiao Wang, Zhen Mao, Zuohong Li, Wuyou Gao, Yixin Qu, Xingyi Li, Yuzhen Jiang, Xianchai Lin","doi":"10.1136/bjo-2024-325581","DOIUrl":null,"url":null,"abstract":"Aims This study evaluates the long-term efficacy and safety of carbon dioxide (CO₂) laser excision as a novel treatment for large xanthelasma palpebrarum. Methods The study included 295 patients diagnosed with xanthelasma palpebrarum, categorised as 246 patients with grade I, 16 with grade II, 22 patients with grade III and 11 with grade IV lesions. All underwent CO₂ laser excision and were followed up for a 12-month period. Treatment efficacy was assessed through clearance and recurrence rates, evaluated using digital photography and complications were recorded. Results The participant group consisted of 66 males and 229 females, with an average age of 41.7±11.6 years. Clearance rates exceeded 99% for grades I–III and were around 95% for grade IV lesions. The recurrence rate was 6.8%, with higher recurrence rates observed in lesions over 2 mm in height compared with those under 2 mm (p<0.001). The main complications over the 12-month follow-up were scarring (4.4%), hyperpigmentation (8.1%) and hypopigmentation (8.5%), with no severe complications reported. Conclusion CO₂ laser excision emerges as a precise, minimally invasive and effective modality for treating xanthelasma palpebrarum, marking a significant advancement in treatment modalities. Further research is required to reinforce these results and refine treatment protocols. Data are available on reasonable request. The data including deidentified participant photographs are available on reasonable request (wangdq5@mail2.sysu.edu.cn).","PeriodicalId":9313,"journal":{"name":"British Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Carbon dioxide laser excision as a novel treatment for large xanthelasma palpebrarum: long-term efficacy and safety\",\"authors\":\"Dingqiao Wang, Zhen Mao, Zuohong Li, Wuyou Gao, Yixin Qu, Xingyi Li, Yuzhen Jiang, Xianchai Lin\",\"doi\":\"10.1136/bjo-2024-325581\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims This study evaluates the long-term efficacy and safety of carbon dioxide (CO₂) laser excision as a novel treatment for large xanthelasma palpebrarum. Methods The study included 295 patients diagnosed with xanthelasma palpebrarum, categorised as 246 patients with grade I, 16 with grade II, 22 patients with grade III and 11 with grade IV lesions. All underwent CO₂ laser excision and were followed up for a 12-month period. Treatment efficacy was assessed through clearance and recurrence rates, evaluated using digital photography and complications were recorded. Results The participant group consisted of 66 males and 229 females, with an average age of 41.7±11.6 years. Clearance rates exceeded 99% for grades I–III and were around 95% for grade IV lesions. The recurrence rate was 6.8%, with higher recurrence rates observed in lesions over 2 mm in height compared with those under 2 mm (p<0.001). The main complications over the 12-month follow-up were scarring (4.4%), hyperpigmentation (8.1%) and hypopigmentation (8.5%), with no severe complications reported. Conclusion CO₂ laser excision emerges as a precise, minimally invasive and effective modality for treating xanthelasma palpebrarum, marking a significant advancement in treatment modalities. Further research is required to reinforce these results and refine treatment protocols. Data are available on reasonable request. The data including deidentified participant photographs are available on reasonable request (wangdq5@mail2.sysu.edu.cn).\",\"PeriodicalId\":9313,\"journal\":{\"name\":\"British Journal of Ophthalmology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/bjo-2024-325581\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bjo-2024-325581","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的 本研究评估了二氧化碳(CO₂)激光切除术作为治疗大面积睑黄褐斑新方法的长期疗效和安全性。方法 该研究纳入了 295 名确诊为睑黄褐斑的患者,分为 246 名 I 级患者、16 名 II 级患者、22 名 III 级患者和 11 名 IV 级患者。所有患者都接受了 CO₂ 激光切除术,并接受了为期 12 个月的随访。治疗效果通过清除率和复发率进行评估,使用数码照片进行评估,并记录并发症。结果 参试者包括 66 名男性和 229 名女性,平均年龄为(41.7±11.6)岁。I-III级病灶的清除率超过99%,IV级病灶的清除率约为95%。复发率为 6.8%,高度超过 2 毫米的病灶复发率高于高度低于 2 毫米的病灶(P<0.001)。随访 12 个月的主要并发症是瘢痕(4.4%)、色素沉着(8.1%)和色素减退(8.5%),没有严重并发症的报告。结论 CO₂激光切除术是治疗睑黄褐斑的一种精确、微创、有效的方法,标志着治疗方法的重大进步。要巩固这些成果并完善治疗方案,还需要进一步的研究。如有合理要求,可提供相关数据。如提出合理要求,可提供数据(包括去身份化的参与者照片)(wangdq5@mail2.sysu.edu.cn)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Carbon dioxide laser excision as a novel treatment for large xanthelasma palpebrarum: long-term efficacy and safety
Aims This study evaluates the long-term efficacy and safety of carbon dioxide (CO₂) laser excision as a novel treatment for large xanthelasma palpebrarum. Methods The study included 295 patients diagnosed with xanthelasma palpebrarum, categorised as 246 patients with grade I, 16 with grade II, 22 patients with grade III and 11 with grade IV lesions. All underwent CO₂ laser excision and were followed up for a 12-month period. Treatment efficacy was assessed through clearance and recurrence rates, evaluated using digital photography and complications were recorded. Results The participant group consisted of 66 males and 229 females, with an average age of 41.7±11.6 years. Clearance rates exceeded 99% for grades I–III and were around 95% for grade IV lesions. The recurrence rate was 6.8%, with higher recurrence rates observed in lesions over 2 mm in height compared with those under 2 mm (p<0.001). The main complications over the 12-month follow-up were scarring (4.4%), hyperpigmentation (8.1%) and hypopigmentation (8.5%), with no severe complications reported. Conclusion CO₂ laser excision emerges as a precise, minimally invasive and effective modality for treating xanthelasma palpebrarum, marking a significant advancement in treatment modalities. Further research is required to reinforce these results and refine treatment protocols. Data are available on reasonable request. The data including deidentified participant photographs are available on reasonable request (wangdq5@mail2.sysu.edu.cn).
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.30
自引率
2.40%
发文量
213
审稿时长
3-6 weeks
期刊介绍: The British Journal of Ophthalmology (BJO) is an international peer-reviewed journal for ophthalmologists and visual science specialists. BJO publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. It also provides major reviews and also publishes manuscripts covering regional issues in a global context.
期刊最新文献
At a glance Deep learning-based normative database of anterior chamber dimensions for angle closure assessment: the Singapore Chinese Eye Study In vivo lacrimal gland imaging artefact assessment based on swept-source optical coherence tomography for dry eye disease Use of immunomodulatory treatment for non-infectious uveitis: an International Ocular Inflammation Society report of real-world practice Longitudinal OCTA vessel density loss in macula and optic nerve head in healthy, glaucoma suspect and established glaucoma eyes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1